Orexigen Therapeutics Cash and Equivalents
Orexigen Therapeutics Cash and Equivalents Chart
Orexigen Therapeutics Historical Cash and Equivalents DataPro Data Export
There is no data for the selected date range.
|Data for this Date Range|
|Dec. 31, 2012||Go Pro|
|Sept. 30, 2012||Go Pro|
|June 30, 2012||Go Pro|
|March 31, 2012||Go Pro|
|Dec. 31, 2011||Go Pro|
|Sept. 30, 2011||Go Pro|
|June 30, 2011||Go Pro|
|March 31, 2011||Go Pro|
|Dec. 31, 2010||Go Pro|
|Sept. 30, 2010||Go Pro|
|June 30, 2010||Go Pro|
|March 31, 2010||Go Pro|
|Dec. 31, 2009||Go Pro|
|Sept. 30, 2009||Go Pro|
About Cash and Equivalents
Cash and equivalents is cash or cash equivalents that a company possesses at any given time. Examples of cash equivalents are: money market accounts, treasury bills, and short term government bonds. Cash and cash equivalents are a business' most liquid assets. Cash on hand results from a positive cash flow statement.
Investors look at cash on hand as a reflection of a company's solvency and liquidity.
View Cash and Equivalents for OREX.
Start Your YCharts Pro Platinum Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $199/month, and comes with a 14-day free trial.Get Started Now
Already a YCharts Pro Platinum Member? Sign in here.
OREX Cash and Equivalents Benchmarks
|Arena Pharmaceuticals||Go Pro|
|Sucampo Pharmaceuticals||Go Pro|
OREX Cash and Equivalents Rankings
2110 of 8009
176 of 687 in Healthcare
22 of 69 in Drug Manufacturers - Specialty & Generic
OREX Cash and Equivalents Range, Past 5 Years
|Minimum||Go Pro||Sep 2010|
|Maximum||Go Pro||Dec 2011|
Fool May 24
Fool May 23
Fool May 22
Fool May 20
PR Newswire May 17